Skip to main content
The BMJ logoLink to The BMJ
letter
. 1996 Sep 14;313(7058):687. doi: 10.1136/bmj.313.7058.687

Use of hormone replacement therapy. Hormone replacement therapy may not always be right choice to prevent cardiovascular disease.

S Panico, R Galasso, E Celentano, L Frova, R Capocaccia, F Berrino
PMCID: PMC2351996  PMID: 8811770

Full text

PDF

Page 687

687

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Colditz G. A., Hankinson S. E., Hunter D. J., Willett W. C., Manson J. E., Stampfer M. J., Hennekens C., Rosner B., Speizer F. E. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995 Jun 15;332(24):1589–1593. doi: 10.1056/NEJM199506153322401. [DOI] [PubMed] [Google Scholar]
  2. Daly E., Roche M., Barlow D., Gray A., McPherson K., Vessey M. HRT: an analysis of benefits, risks and costs. Br Med Bull. 1992 Apr;48(2):368–400. doi: 10.1093/oxfordjournals.bmb.a072552. [DOI] [PubMed] [Google Scholar]
  3. Grady D., Rubin S. M., Petitti D. B., Fox C. S., Black D., Ettinger B., Ernster V. L., Cummings S. R. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992 Dec 15;117(12):1016–1037. doi: 10.7326/0003-4819-117-12-1016. [DOI] [PubMed] [Google Scholar]
  4. Psaty B. M., Heckbert S. R., Atkins D., Siscovick D. S., Koepsell T. D., Wahl P. W., Longstreth W. T., Jr, Weiss N. S., Wagner E. H., Prentice R. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women. Arch Intern Med. 1993 Jun 28;153(12):1421–1427. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES